Krystina Dunston on Using Targeted Therapy to Slow Endometrial Cancer
A Novel Prognostic Biomarker in Head and Neck Cancer
First Patient Dosed in VIRO-25 Trial of Olvimulogene Nanivacirepvec for NSCLC